These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30191912)

  • 1. Successful intravenous thrombolysis of a wake-up stroke with underlying valvular atrial fibrillation.
    Shahedah KK; Khoo CS; Wan Nur Nafisah WY; Ng CF; Noor Ashikin I; Mohd Naim MY; Syazarina Sharis O; Rozman Z; Wan Asyraf WZ
    J R Coll Physicians Edinb; 2018 Sep; 48(3):239-241. PubMed ID: 30191912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Associated with Thrombolysis Outcome in Ischemic Stroke Patients with Atrial Fibrillation.
    Zhao Q; Li X; Dong W; Ye M; Cao Y; Zhang M; Cheng Q; Zhou J; Chen G; Yu M; Hong S; Wei X; Wang B; Cui G; Zhang P; Ding H; Xu R; Chen Y; Xu Y
    Neurosci Bull; 2016 Apr; 32(2):145-52. PubMed ID: 26951522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease in blood pressure after intravenous administration of urapidil during recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke.
    Bugnicourt JM; Duru C; Picard C; Godefroy O
    Clin Ther; 2008 Sep; 30(9):1675-80. PubMed ID: 18840373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.
    Schellinger PD; Jansen O; Fiebach JB; Heiland S; Steiner T; Schwab S; Pohlers O; Ryssel H; Sartor K; Hacke W
    Stroke; 2000 Jun; 31(6):1318-28. PubMed ID: 10835451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intravenous thrombolysis on stroke associated with atrial fibrillation.
    Padjen V; Jovanovic D; Berisavac I; Ercegovac M; Stefanovic Budimkic M; Stanarcevic P; Beslac Bumbasirevic L
    J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2199-2205. PubMed ID: 25018112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous Thrombolysis Increases the Rate of Dramatic Recovery in Patients with Acute Stroke with an Unknown Onset Time and Negative FLAIR MRI.
    Aoki J; Sakamoto Y; Kimura K
    J Neuroimaging; 2016 Jul; 26(4):414-9. PubMed ID: 27388586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients.
    Alvarez-Sabín J; Molina CA; Montaner J; Arenillas JF; Huertas R; Ribo M; Codina A; Quintana M
    Stroke; 2003 May; 34(5):1235-41. PubMed ID: 12677014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective, open-label safety study of intravenous recombinant tissue plasminogen activator in wake-up stroke.
    Barreto AD; Fanale CV; Alexandrov AV; Gaffney KC; Vahidy FS; Nguyen CB; Sarraj A; Rahbar M; Grotta JC; Savitz SI;
    Ann Neurol; 2016 Aug; 80(2):211-8. PubMed ID: 27273860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-contrast brain ct based systemic thrombolysis of two wake up ischemic stroke patients in rural settings].
    Pozsegovits K; Rencz L; Csúsz L; Szabó G
    Ideggyogy Sz; 2017 May; 70(5-6):209-212. PubMed ID: 29870636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen Activator.
    Bissig D; Manjunath R; Traylor BR; Richman DP; Ng KL
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):e102-e104. PubMed ID: 28416406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends of r-tPA (Recombinant Tissue-Type Plasminogen Activator) Treatment and Treatment-Influencing Factors in Acute Ischemic Stroke.
    Marko M; Posekany A; Szabo S; Scharer S; Kiechl S; Knoflach M; Serles W; Ferrari J; Lang W; Sommer P; Greisenegger S;
    Stroke; 2020 Apr; 51(4):1240-1247. PubMed ID: 32114931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolysis in Real Time: Demonstration of Revascularization with Intravenous Thrombolysis Therapy in the CT Scanner.
    Tan J; Aysenne A; Singh V
    J Neuroimaging; 2017 Jan; 27(1):50-58. PubMed ID: 27653945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reperfusion and outcomes in Penumbra vs. systemic tissue plasminogen activator clinical trials.
    Alexandrov AV; Schellinger PD; Saqqur M; Barreto A; Demchuk AM; Ribo M; Rubiera M; Sharma VK; Heliopoulos I; Alexandrov AW; Molina CA; Tsivgoulis G;
    Int J Stroke; 2011 Apr; 6(2):118-22. PubMed ID: 21371272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke.
    Saver JL; Goyal M; Bonafe A; Diener HC; Levy EI; Pereira VM; Albers GW; Cognard C; Cohen DJ; Hacke W; Jansen O; Jovin TG; Mattle HP; Nogueira RG; Siddiqui AH; Yavagal DR; Devlin TG; Lopes DK; Reddy V; du Mesnil de Rochemont R; Jahan R;
    Int J Stroke; 2015 Apr; 10(3):439-48. PubMed ID: 25777831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of major improvement after intravenous thrombolysis in acute ischemic stroke.
    Yaghi S; Hinduja A; Bianchi N
    Int J Neurosci; 2016; 126(1):67-9. PubMed ID: 25562545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of hyperdense middle cerebral artery sign on follow-up CT scan after intravenous thrombolysis is associated with poor outcome.
    Paliwal PR; Ahmad A; Shen L; Yeo LL; Loh PK; Ng KW; Chong VF; Ong BK; Venketasubramanian N; Sinha AK; Teoh HL; Bathla G; Chan BP; Sharma VK
    Cerebrovasc Dis; 2012; 33(5):446-52. PubMed ID: 22456065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does intravenous rtPA benefit patients in the absence of CT angiographically visible intracranial occlusion?
    Sylaja PN; Dzialowski I; Puetz V; Eliasziw M; Hill MD; Krol A; O'Reilly C; Demchuk AM
    Neurol India; 2009; 57(6):739-43. PubMed ID: 20139502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-Vessel Occlusion Stroke: Effect of Recanalization on Outcome Depends on the National Institutes of Health Stroke Scale Score.
    Skagen K; Skjelland M; Russell D; Jacobsen EA
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1532-9. PubMed ID: 25922156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.
    Ong CT; Wong YS; Wu CS; Su YH
    Drug Des Devel Ther; 2017; 11():1559-1566. PubMed ID: 28572721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.